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Abbreviations: Aβ, β-amyloid protein; AD, Alzheimer’s disease; ALS, amyotrophic 1 
lateral sclerosis; AO, antisense oligonucleotide; ATCC, American Type Culture Collection; 2 
BBB, blood–brain barrier; CA, caffeoylquinic acid; CBB, coomassie brilliant blue; CQA, 3 
caffeoylquinic acid; IEF,  isoelectric focusing; MALDI-ToF, matrix assisted laser 4 
desorption ionization-time of flight; MWM, Morris water maze; SAMP, senescence-5 
accelerated-prone mice; SAMR, senescence-accelerated-resistant mice; PGK1, 6 
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Abstract-As aged population dramatically increases in these decades, efforts should be 1 
made on the intervention for curing age-associated neurologic degenerative diseases such 2 
as Alzheimer’s disease (AD). Caffeoylquinic acid (CQA), an antioxidant component and its 3 
derivatives are natural functional compounds isolated from a variety of plants. In this study, 4 
we determined the neuroprotective effect of 3,5-di-O-CQA on Aβ1–42 treated SH-SY5Y 5 
cells using MTT assay. To investigate the possible neuroprotective mechanism of 3,5-di-O-6 
CQA, we performed proteomics analysis, real-time PCR analysis and measurement of the 7 
intracellular ATP level. In addition, we carried out the measurement of escape latency time 8 
to find the hidden platform in Morris water maze (MWM), real-time PCR using 9 
senescence-accelerated-prone mice (SAMP) 8 and senescence-accelerated-resistant mice 10 
(SAMR) 1 mice. Results showed that 3,5-di-O-CQA had neuroprotective effect on Aβ 1–42 11 
treated  cells. The mRNA expression of glycolytic enzyme (phosphoglycerate kinase-1; 12 
PGK1) and intracellular ATP level were increased in 3,5-di-O-CQA treated SH-SY5Y cells. 13 
We also found that 3,5-di-O-CQA administration induced the improvement of spatial 14 
learning and memory on SAMP8 mice, and the overexpression of PGK1 mRNA. These 15 
findings suggest that 3,5-di-O-CQA has a neuroprotective effect on neuron through the 16 
upregulation of PGK1 expression and ATP production activation. 17 
  18 
 19 
 20 
 21 
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The major reason of aging is the functional decrease of energy production in the body.  1 
Aging is usually associated with the accumulation of reactive oxygen species (ROS)-2 
mediated oxidative damage, which can induce the decrease in intracellular ATP levels via 3 
the functional decline of mitochondrion. Intracellular ATP depletion causes cell death in 4 
neuronal cells, leading to neurodegenerative diseases such as Alzheimer’s disease (AD), 5 
amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (Beal et al., 1995; Huaug et al., 6 
2001). AD, in particular, is one of the diseases with increasing number of patients with age-7 
related neurodegenerative disorders, and is a degenerative disorder of the central nervous 8 
system, which causes mental deterioration and progressive dementia. AD is accompanied 9 
by neuropathologic lesions including the presence of senile plaques of the β-amyloid 10 
protein (Aβ), an etiological role in AD. The overexpression of Aβ protein and its fibrillar 11 
deposition in senile plaques have been correlated with the progression of cognitive 12 
impairment in AD (Eckert et al., 2003; Roth, 2001; Holliday, 1996). 13 
One of the animal models that is used to study AD and aging is the senescence-14 
accelerated mouse (SAM). The SAM model was developed in 1981, which originally 15 
consisted of nine major senescence-accelerated-prone mice (SAMP) substrains and three 16 
major senescence-accelerated-resistant mice (SAMR) substrains, each of which exhibits the 17 
characteristic disorders. Thereafter, selective inbreeding was applied based on the degree of 18 
senescence, the lifespan, and the age-associated pathologic phenotypes (Hosokawa et al., 19 
1997; Takeda et al., 1981). The SAMP8 strain exhibits age-related deterioration in memory 20 
and learning (Yagi et al., 1988; Ohta et al., 1989) along with the overexpression of amyloid 21 
precursor protein (APP) (Li et al., 2009; Nomura et al., 1996; Morley et al., 2000). SAMP8 22 
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mice also show decreased glucose metabolism (Poon et al., 2005; Shimano, 1998), which is 1 
a characteristic of AD wherein energy metabolism is impaired (Blass et al., 1988). The 2 
decrease in the production of Aβ, after giving an intracerebroventricular injection of a 42-3 
mer phosphorothiolated antisense oligonucleotide (AO) directed at the Aβ region of the 4 
APP gene, can reduce lipid peroxidation and protein oxidation and improve cognitive 5 
deficits in aged SAMP8 mice. Therefore, SAMP8 is a good model to study brain aging and 6 
is used as one mouse model of AD.  7 
 Caffeoylquinic acid (CQA) derivatives are natural functional compounds isolated 8 
from a variety of plants and  possess a broad range of pharmacological properties, 9 
including antioxidant, hepatoprotectant, antibacterial,  antihistaminic, anticancer, and 10 
other biological effects (Basnet et al., 1996; Kwon et al., 2000; Nakajima et al., 2005). 11 
Recently, it  has been demonstrated that CQA derivatives  possess neuroprotective 12 
effects in Aβ-induced PC12 cell toxicity (Hur et al., 2001) and in tetrahydropapaveroline 13 
(THP)-induced C6 glioma cell death (Soh et al., 2003). Moreover, CQA exhibited a 14 
neuroprotective function against in vitro cell death and in vivo ischemia-induced neuronal 15 
damage. However, the mechanism by which these caffeoylquinic acid derivatives exert 16 
neuroprotection is unclear. 17 
In this study, we used a SH-SY5Y human neuroblastoma cell line as the Aβ-18 
induced neuronal cell death model and the SAMP8 mice as the in vivo AD model, to 19 
determine a pharmacological function for the the neuroprotective properties of 3,5-di CQA. 20 
Furthermore, to investigate the mechanism for the neuroprotective effect of 3,5-di CQA, we 21 
have performed (2D)-polyacrylamide-gel electrophoresis (PAGE), matrix assisted laser 22 
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desorption ionization-time of flight (MALDI-ToF) mass spectrometry analysis and real 1 
time PCR.  2 
 3 
EXPERIMENTAL PROCEDURRS 4 
Cell culture 5 
The human neuroblastoma clonal SH-SY5Y cell line was obtained from American Type 6 
Culture Collection (ATCC). Cultures were maintained in serum-containing medium (1:1 7 
mixture of Dulbecco's modified Eagle's medium and Ham's nutrient mixture F-12), 8 
supplemented with 15% fetal bovine serum and MEM non-essential amino acids. Cells 9 
were maintained at 37°C under 5% CO2 / 95% air. To culture for the subsequent extraction 10 
of protein and total RNA, cells were seeded onto Petri plates at a density of 2 x 106 cells per 11 
dish, and 3,5-di-O-CQA was added at a final concentration of 20 μM.  12 
 13 
Determination of cell viability 14 
To investigate the neuroprotective effect, we employed the Aβ-treated SH-SY5Y cell 15 
model (Li et al., 1996; Wang et al., 2009). Cell viability was assessed using the 16 
conventional MTT reduction assay. The cultured cells in 96-well plates (fibronectin coated 17 
plate) were treated with 3,5-di-O-CQA and exposed to 2 μM Aβ1–42 for 72 h, then 10 μl of 18 
MTT stock solution (5 mg/ml) was added to the culture medium and incubated for 6 h at 19 
37 °C. The formazan was extracted with 100 μl 10% SDS (W/V) and the absorbance was 20 
measured with a microtiter plate reader.  21 
 22 
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Two-dimensional gel electrophoresis (2-DE) 1 
2-DE was performed essentially as described by Isoda et al. (2006) with modifications.  2 
Samples containing 30 µg for analytical gels or 300 µg for preparative gels of  protein were 3 
separated by isoelectric focusing (IEF) and then by sodium dodecyl sulfate polyacrylamide 4 
gel eletrophoresis (SDS-PAGE) using Ettan IPGphor II and Ettan DALTsix (GE Healthcare, 5 
Uppsala, Sweden).  For IEF, samples were added into the rehydration solution containing 8 6 
M urea, 2% CHAPS, 0.5% IPG buffer, 0.002% bromophenol blue and 0.28% (w/v) 7 
dithiothreitol (DTT), and then applied to a 24cm immobiline dry strips, which are dry 8 
polyacrylamide gel strips with an immobilized pH gradient pH 3-10 (GE Healthcare).  The 9 
dry strips were rehydrated at 20 ℃ for 12 h and isoelectric focusing of proteins was carried 10 
out at 500 V for 1 h, 1000 V for 1 h, 10000 V for 3 h, 10000 V for 2 h, and, 45 min.  11 
Thereafter, IPG strips were reduced (1% DTT) and alkylated (2.5% iodoacetamide) in 12 
equilibration buffer (6 M urea, 50 mM Tris-Cl, pH 8.8, 30% glycerol, 2% SDS).  When the 13 
equilibration was finished, the strips were loaded onto 12% acrylamide vertical gels and 14 
separation of proteins with different molecular weight was carried out at 2.5 W per gel for 15 
30 min, followed by 25 W per gel for 3.5 h. 16 
Silver staining using Plus One Silver Staining Kit (GE Healthcare) was performed 17 
according to the manufacturer’s instructions. The stained gels were subjected to image 18 
analysis by ImageMaster 2D Platinum software (ver. 4.9; GE Healthcare).  Gels in which 19 
proteins from either β-amyloid (Aβ) or caffeoylquinic acid (CA) treatment, or both, as well 20 
as control were imported into the same platform and were subjected to image analysis.  21 
After spot detection and matching, the spots of interest were manually selected  and the 22 
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data regarding the relative intensities of these spots were obtained. Spots intensities were 1 
expressed as percentages (% vol) of relative volumes by integrating the value (or OD) of 2 
each pixel in the spot area (vol) and dividing it with the sum of the volumes of all the spots 3 
detected in the gel. 4 
 5 
In-gel digestion and mass spectrometry 6 
For spot picking, preparative gels in which quantity of protein was ten times more than that 7 
in analytical gels, were prepared. After coomassie brilliant blue (CBB) staining using 8 
Coomassie Tablets, PhastGel R-350 (GE Healthcare), the protein spots of interest were 9 
excised and put into 1.5 ml eppendorf tubes. After destaining, the spots were digested with 10 
trypsin (sequencing grade, GE Healthcare) and the peptides were extracted.  Prior to 11 
analysis on mass spectrometer, the peptide solutions were desalted by Zip Tip C18 12 
(Millpore, Tokyo, Japan). The peptide solutions were then applied onto MALDI plate 13 
directly and the solution drop was allowed to air-dry. Furthermore, the matrix solution, 14 
prepared by dissolving 10 mg of α-cyano-4-hydroxycinnamic acid (CHCA, Sigma, USA) 15 
in 1 ml of 50% acetonitrile and 0.1% triflouroacetic acid in deionized water, was overlayed 16 
onto the dried drops. After the matrix solution was dried, the plate was inserted into the 17 
MALDI-TOF mass spectrometer and was subjected to peptide mass fingerprinting. All the 18 
MALDI-TOF mass spectra were acquired on AXIMA-CFR mass spectrometer. The 19 
acquired MS spectra were searched against NCBI database using the MASCOT 20 
(www.matrixscience.com) MS search engine. The search parameters were the following: 21 
type of search, peptide mass fingerprint; enzyme, trypsin; fixed modification, 22 
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carbamidomethyl (C); variable modifications, oxidation (M); mass values, monoisotopic; 1 
protein mass, unrestricted; peptide mass tolerance, 0.2 Da; peptide charge state, 1; max 2 
missed cleavages, 2. 3 
 4 
Real-time PCR 5 
To find the trigger genes on the neuroprotective effect of 3,5-di-O-CQA, we considered the 6 
lower concentration (10 μM ) and shorter treatment time (16 h). After incubating seeded 7 
plates for 16 h, total RNA was purified using the ISOGEN kit (Nippon Gene Co. Ltd., 8 
Japan). Total RNA was quantified by measurement of the spectrophotometer at 260 nm 9 
with a UV spectrophotometer and was also measured at 280 nm to assess purity. Only RNA 10 
with a 260/280 ratio higher than 1.8 was used for real-time PCR. The template cDNA was 11 
synthesized from total RNA using the SuperScript reverse transcriptase system (Invitrogen). 12 
Briefly, RNA was denatured at 65 ℃ for 5 min and incubated with 1 µL oligo (dT)12-15 13 
primers and chilled at 4℃. After adding SuperScript II reverse transcriptase (200 units) the 14 
reaction mix was incubated at 42℃  for 60 min, then 10 min at 70℃ (16). For the 15 
quantification of mRNA, nested primers were designed using Primer3 input software 16 
(http://frodo.wi.mit.edu/cgi-bin/primer3/ primer3.cgi/primer3_www.cgi). Quantitative PCR 17 
reactions were performed in a MiniOpticon instrument (Bio-Rad, USA) and carried out as 18 
recommended for iQ SYBRGreen supermix (Bio-Rad). Briefly, the RT mix (2 µL) was 19 
used as template for the real-time PCR mix containing 0.5 mM forward (5’ 20 
ACAATGGAGCCAAGTCGGTAG-3’) and reverse (5’-21 
GCCTACACAGTCCTTCAAGAAC-3’) nested primers (2 µL each) and 2 x SYBR Green 22 
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supermix (10 μL). The amplification conditions were: 3 min at 95℃, 10 s at 95℃, 30 s at 1 
62℃,  and 30 s at 72℃ for 34 cycles. At the end of the reaction, a melting curve analysis 2 
was carried out to check for the presence of primer-dimers. 3 
 4 
Measurement of Intracellular ATP Content. 5 
ATP was assessed as firefly bioluminescence using the luminescence luciferase assay kit 6 
(TOYO Ink, Tokyo, Japan). To determine the increase of intracellular ATP content due to 7 
3,5-di-O-CQA treatment SH-SY5Y cells (2 x 103 cells/well) were pretreated for 48 h with 8 
3,5-di-O-CQA (10 and 20 μM) after which, cells were lysed with 100 μL of lysis buffer 9 
(Toyo ink) and placed directly into the chamber of a luminometer (Powerscan HT; 10 
Dainippon Pharmaceutical, Osaka, Japan). Light emission was recorded after the addition 11 
of 100 μL of luciferin-luciferase solution (Toyo ink). When ATP is the limiting component 12 
in a luciferase reaction, the intensity of light emitted is proportional to the concentration of 13 
ATP in the cytosolic extracts. 14 
 15 
Animals and supplementation 16 
Male SAMP8 and SAMR1 mice were provided by the Japan SLC company. Three mice 17 
were housed per cage with a 12-h light/dark cycle. The animals had free access to food and 18 
water. After a 7-day acclimatization to the laboratory conditions, 3 month old SAMP8 mice 19 
(n=20) were randomly divided into two groups: SAMP8 control group (n=10), 3,5-di-O-20 
CQA-supplemented group (n=10), while age matched SAMR1 mice (n=10) served as the 21 
normal aging control. The 3,5-di-O-CQA-treated mice were orally administered with 3,5-22 
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di-O-CQA mixed with drinking water (6.7 mg/kg・ day) for 1 month using oral 1 
administration tube and syringe.  2 
 3 
Morris water maze (MWM) 4 
After the open field test, the MWM was selected as a method for the evaluation of the 5 
spatial learning and memory. A circular water tank (120 cm in diameter and 50 cm in 6 
height) was filled with water to a depth of 30 cm. Inside the tank, an escape platform (11 7 
cm in diameter) was placed, with the top of 1 cm below the water surface. The platform 8 
was in the middle of the target quadrant, and its position remained fixed during the 9 
experiment. Above the tank, a white floor-to-ceiling cloth curtain was drawn around the 10 
pool, and four kinds of black cardboard (circle, triangular, rhombus and square) were hung 11 
equidistantly on the interior of the curtain serving as spatial cues. Each mouse had daily 12 
sessions of one trial for 30 consecutive days. When they succeeded, mice were allowed to 13 
stay on the platform for 30 s. When the mice failed to find the platform within 60 s, they 14 
were assisted by the experimenter and allowed to stay the platform for the same time. A 15 
probe trial was performed 24 h after the last training session. In this trial, the platform was 16 
removed from the tank and mice were allowed to swim freely for 60 s. 17 
 18 
Statistical analysis 19 
The escape latency of mice in the MWM training was analyzed using the two-way analysis 20 
of variance (ANOVA) with repeated measures, the factors being treatment and training day. 21 
One-way ANOVA was used to analyze group differences for the data collected in the swim 22 
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speed analysis, the MWM probe trial, and the open field test, Nissl staining and Western 1 
blotting, followed by LSD (equal variances assumed) or Tamhane’s T2 (equal variances not 2 
assumed) post hoc tests. A criterion of P<0.05 was considered significant and the results 3 
were expressed as mean±SEM. 4 
 5 
RESULTS 6 
Neuroprotective effect of CQA on Aβ1–42-induced neuronal death 7 
In order to eliminate the possible neuroprotective effect of 3,5-di-O-CQA, we examined the 8 
cell viability when treated with 3,5-di-O-CQA and Aβ1–42. SH-SY5Y cells were incubated 9 
in the presence or in the absence of 2 µM Aβ1–42 for 72h and the neuronal survival 10 
determined by MTT assays. Fig. 1 shows the MTT result of cells treated for 72 h with 10 11 
µM Aβ1–42, and treated with 20 µM 3,5-di-O-CQA. The cell viability of Aβ1–42 treated cells 12 
was significantly decreased to 74.2%±7.6 compared with the non-treated group (P<0.01). 13 
In addition, we investigated the effect of 3,5-di-O-CQA on preventing decreased cell 14 
viability in SH-SY5Y cells induced by Aβ1–42. Incubation with 20 µM 3,5-di-O-CQA 15 
reversed the Aβ1–42-induced cell death and the cell viability significantly increased to 16 
106.5%±9.8 compared to the non-treated group (P<0.01). Interestingly, the cell viability 17 
of 3,5-di-O-CQA treated cells, without Aβ1–42 treatment, significantly increased to 124.6%18 
±9.8 compared to the non-treated group (P<0.01) 19 
 20 
Effect of CQA and/or Aβ treatment on proteins expression profiles of SH-SY5Y cells 21 
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To examine the possible mechanism involved in the neuroprotective effect of 3,5-di-O-1 
CQA on neuronal cells, we performed a proteomics analysis on Aβ1–42-treated SH-SY5Y 2 
cells with or without 3,5-di-O-CQA treatment. Proteins were extracted from the CQA 3 
and/or Aβ treated SH-SY5Y cells, which had been treated for 72 h, and the total proteins 4 
separated by 2D-gel electrophoresis. A protein pattern of SH-SY5Y cells is shown in Fig. 5 
2A. Approximately 2000 spots were detected in each silver-stained gel, with molecular- 6 
mass ranges of 15 to 200 kDa and a pI, that ranges from 3 to 10. Many spots from CQA 7 
and/or Aβ-treated SH-SY5Y cells were increased or decreased on each gel. As shown in 8 
Fig. 2B, Aβ1–42 treatment caused a substantial decrease in a particular spot. However, 3,5-9 
di-O-CQA treatment induced up-regulation of a particular spot under Aβ1–42 treatment. The 10 
spot protein had a relative molecular mass of 40-45 kDa and an isoelectric point in the 11 
range of 7.0-7.6 (Boxed region). To identify this protein, the spot was excised and 12 
subjected to tryptic digestion and MALDI-ToF mass spectrometry analysis. The results of 13 
the database searches showed that the protein sequence most closely corresponded to that 14 
of human phosphoglycerate kinase-1 (PGK1), with matching peptides covering 67% of 15 
PGK1 (281/417 amino acids).  16 
 17 
Effect of CQA on the mRNA expression level of PGK1 18 
In order to determine the effect of 3,5-di-O-CQA on the mRNA expression level of PGK1, 19 
which is overexpressed by  3,5-di-O-CQA treatment on protein level, we performed the 20 
real-time PCR analysis using β-actin as a control gene. As shown in Fig. 3, the mRNA 21 
expression level of PGK1 was highly increased by 20 μM  3,5-di-O-CQA treatment on SH-22 
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SY5Y cells. In fact, the mRNA expression level of PGK1 was significantly upregulated by 1 
119% ±7.2 compared with the non-treated group (P<0.05). 2 
 3 
Effects of CQA on intracellular ATP production 4 
Based on the results of proteomics analysis and real-time PCR, 3,5-di-O-CQA induced the 5 
increase in PGK1 expression. The PGK1 protein is one of glycolytic enzymes of glycolysis. 6 
To investigate the upregulated glycolytic enzyme’s effects on energy generation, the levels 7 
of ATP, which is the end product of glycolysis, were evaluated. ATP is a multifunctional 8 
nucleotide that is important as a “molecular currency” of intracellular energy transfer. In 9 
this role, ATP transports chemical energy within cells for metabolism. Intracellular ATP 10 
production level of 3,5-di-O-CQA-treated SH-SY5Y cells was measured by a luciferase 11 
reaction method. In  3,5-di-O-CQA-treated SH-SY5Y cells, luminescence was significantly 12 
upregulated by 113% ±7.2 compared to non-treated group (P<0.05) (Fig. 4).  13 
 14 
Effect of CQA on spatial learning and memory of SAMP8 mice in MWM 15 
We measured the time, swimming time to arrive at the platform (escape latency time), to 16 
assess the effect of 3,5-di-O-CQA on spatial learning and memory, which is AD’s major 17 
symptom. We noted that the 3 month-old SAMP8 and SAMR1 mice demonstrated 18 
significant differences in motivational swimming speed between groups (data not shown). 19 
As shown in Fig. 5, all groups (SAMP8, SAMP8+CQA, SAMR1 group) improved their 20 
performance after 30 days. However, the escape latency time of SAMP8 group (n=10) was 21 
slightly decreased, compared with SAMR1 and SAMP8+CQA groups. The escape latency 22 
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time of SAMP8+CQA and SAMR1 group (n=10) was significantly decreased compared to 1 
SAMP8 group (P<0.01). There was no significant difference between SAMP8+CQA and 2 
SAMR1group on the escape latency time.  3 
 4 
Effect of CQA on the mRNA expression level of PGK1 on SAMP8 mice brain 5 
We investigated the mRNA expression level of PGK1 on SAMP8 mice brain to determine 6 
the effect of 3,5-O-di CQA on PGK1 expression in vivo. From the real-time PCR result 7 
(Fig. 6), the mRNA expression level of PGK1 was highly increased in the brain of 3,5-di-8 
O-CQA administrated SAMP8 mice. In fact, the PGK1 mRNA expression in 9 
SAMP8+CQA group was significantly upregulated by 153% ±7.5 compared with the  10 
SAMR1 group (P<0.01). However, the PGK1 mRNA expression in SAMP8 group was 11 
slightly down-regulated compared to SAMR1 group (not significantly). 12 
 13 
DISCUSSION 14 
The pathogenesis of AD has been reported by several researchers who carried out post-15 
mortem determinations. AD is induced by: (1) a cholinergic defect; (2) a glutamatergic 16 
impairment; (3) chromosome 21 impairment which produces β-APP; and (4) the 17 
endothelium impairment of blood–brain barrier (BBB) (Hagino et al., 2004). Senile 18 
dementia is a disease involving a cholinergic defect which is the direct result of the 19 
decreased glucose metabolism in the brain (Meier-Ruge et al., 1984). Since the key 20 
substrate of acetylcholine synthesis is acetylcoenzyme A, which is exclusively synthesized 21 
in the glycolytic pathway in the brain. Glucose matabolism, final products of which are 22 
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ATP and NADH, is the main fuel for all brain cells. The cholinergic defect, nerve cell death 1 
and the amyloid protein accumulation in the brain may be a secondary phenomena caused 2 
by the decline in glucose metabolism in senile dementia (Benson et al., 1983; Tucek et al., 3 
1990). 4 
In the presence of oxygen, glucose undergoes complete combustion to create CO2 5 
and H2O. The energy produce reaction that liberates free energy, which is trapped as ATP 6 
into two consecutive processes: glycolysis and oxidative phosphorylation in mitochondria. 7 
The impairment of glycolytic metabolism of glucose in the endothelium of BBB, and the 8 
dysfunction of glycolysis pathway cause hypoglycemia in the brain which may initiate the 9 
accumulation of amyloid protein in the brain (Hagino et al., 2004). 10 
Our results show that 3,5-di-O-CQA induced the intracellular ATP level in the 11 
human neuroblastoma clonal SH-SY5Y cells. Moreover, 3,5-di-O-CQA induced the 12 
overexpression of PGK1 mRNA on in vivo and in vitro. From these results, we suggest that 13 
the increase of intracellular ATP level is caused by overexpression of PGK1 mRNA in 3,5-14 
di-O-CQA treatment.  Therefore, it is possible that the neuroprotective effect of CQA is 15 
closely related to the energy metabolism activation, glycolysis pathway activation via the 16 
overexpression glycolytic enzyme.  17 
CQA has a variety of physiological activities, antioxidant activity, cell 18 
differentiation, analgesic activity and neuroprotective effect. However, there has been no 19 
report that CQA induced the activation of ATP production in neuronal cells. Our study is 20 
the first report on the new function of CQA as a stimulator of ATP production. Exposure of 21 
neuronal cells to the strict circumstance, such as cell toxic and chronic hypoxia stimulates 22 
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the expression of glucose transporters and enzymes that accelerate glucose utilization to 1 
compensate for the reduced production of ATP (Gao et al., 2004). Such a response is 2 
gradually late and weak in aging cells. From our results, we suggest that CQA contribute to 3 
the homeostasis of ATP production in cells, especially on neuronal cells.  4 
 Futhermore, glycolytic enzymes have glycolytic and non-glycolytic functions. As 5 
for the non-glycolytic functions, glycolytic enzymes play an important role in: (1) 6 
apoptosis; (2) transcriptional regulation; (3) cell motility (Kim et al., 2005; Canback et al., 7 
2002). Some glycolytic enzymes, Hexokinase, GAPD, etc, are implicated in neuronal 8 
apoptosis, and several groups have been investigating thier possible roles in age-related 9 
neurodegenerative disorders such as AD (Zheng et al., 2003; Sirover et al., 1999; Mazzola 10 
et al., 2003). These findings suggest that the activated glycolytic enzymes by CQA 11 
treatment were related to the regulation of neuronal cell apoptosis via apoptosis regulator; 12 
BAD, Bak and Bcl.   13 
The parameter of spatial learning and memory (means of escape latency time to find 14 
the hidden platform) within 6 days in MWM in SAMP8 and SAMR1 mice was similar. 15 
However, 3,5-di-O-CQA, 6.7 mg/kg・day, were shown to have decreased escape latency 16 
time compared to the vehicle-administrated SAMP8 mice for 10-30 days. This dose of 3,5-17 
di-O-CQA also caused an increase in PGK1 mRNA expression in SAMP8 mice brains (Fig. 18 
6). From these results, 3,5-di-O-CQA induced the overexpression of PGK1 mRNA level 19 
both in vitro and in vivo.  20 
Particularly, PGK1 is an important glycolytic enzyme because this enzyme that 21 
induces the production of 2 molecules of ATP in glycolysis pathway. Furthermore, PGK1 22 
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is not a rate limiting enzyme which is Hexokinase, Phosphofructokinase, Pyruvate kinase, 1 
in the glycolysis pathway (Theresa et al., 1982). Therefore, the activation of PGK1 enzyme 2 
is not affected by the feedback inhibition on ATP production. We suggest that 3,5-di-O-3 
CQA can induced the activation of ATP production without feedback inhibition through the 4 
activation of PGK1.  5 
 6 
CONCLUSION 7 
In conclusion, we found that 3,5-di CQA has a neuroprotective effect on Aβ1–42 8 
treated SH-SY5Y cells. The mRNA expression of glycolytic enzyme (PGK1) and the 9 
intracellular ATP level were increased in 3,5-di-O-CQA-treated SH-SY5Y cells. We also 10 
found that 3,5-di-O-CQA administration induced the improvement of spatial learning and 11 
memory on SAMP8 mice, and the overexpression of PGK1 mRNA level. These findings 12 
suggest that 3,5-di-O-CQA has a neuroprotective effect through the induction of PGK1 13 
expression and ATP production activation. 14 
15 
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Fig. 1 Effect of 3,5-di-O-CQA on the Aβ1–42 treated SH-SY5Y cells viability. SH-SY5Y 1 
cells were treated with 20 μM 3,5-di-O-CQA (CQA) or 2 μM Aβ1–42 (Aβ) for 72 h.  2 
Each bar represents the mean ± SD (n = 4). *P<0.05  3 
 4 
Fig. 2 Two-dimensional gel electrophoresis of SH-SY5Y cells (A), the magnified images of 5 
the boxed regions (B) and spot volume (C). SH-SY5Y cells were treated with 20 μM 6 
3,5-di-O-CQA or exposed to 2 μM Aβ1–42 for 72 h,. The 2-DE gel was stained with 7 
coomassie brilliant blue. Spot volume was measured by ImageMaster 2D Platinum 8 
software. These spots were identified as PGK1 by MALDI-TOF mass spectrometry. 9 
Each bar represents the mean ± SD (n = 3). **P<0.01 (vs control). 10 
 11 
Fig. 3 Effect of 3,5-di-O-CQA on the expressions of PGK1 mRNAs by SH-SY5Y cells. β-12 
actin was used as a housekeeping gene. The mRNA expression of PGK1 was 13 
normalized by β-actin mRNA expression. SH-SY5Y cells were treated with 10 μM 14 
3,5-di-O-CQA for 16 h.  Each bar represents the mean ± SD (n = 4). *P<0.05 15 
 16 
Fig. 4 Effect of 3,5-di-O-CQA on the intracellular ATP production of SH-SY5Y cells. SH-17 
SY5Y cells were treated with 10 and 20 μM 3,5-di-O-CQA for 48 h. Intracellular ATP 18 
production was increased by 3,5-di-O-CQA treatment on SH-SY5Y cells. Each bar 19 
represents the mean ± SD (n = 10). **P<0.01 vs control  20 
 21 
32 
 
Fig. 5 Effect of 3,5-di-O-CQA on the spatial learning and memory of SAMP8 mice in 1 
MWM. The average time to reach the hidden platform (latency in seconds) is plotted 2 
for each training day. SAMP8 mice were administrated with 3,5-di-O-CQA (6.7 3 
mg/kg・day) for 30 days.  Each bar represents the mean ± SD (n = 8). *P<0.05 vs 4 
SAMP8 group. 5 
 6 
Fig. 6 Effect of 3,5-di-O-CQA on the expressions of PGK1 mRNAs by SAMR1 and 7 
SAMP8 mice brains. β-actin was used as a housekeeping gene. The mRNA expression 8 
of PGK1 was normalized by β-actin mRNA expression. SAMP8 mice were 9 
administrated with 3,5-di-O-CQA (6.7 mg/kg・day) for 30 days.  Each bar represents 10 
the mean ± SD (n = 8). *P<0.05 11 
 12 
